iCaReMe Global Registry

Trial Identifier: D1690R00044
Sponsor: AstraZeneca
NCTID:: NCT03549754
Start Date: February 2018
Primary Completion Date: December 2025
Study Completion Date: December 2025
Condition: Chronic Kidney Diseases; Congestive Heart Failure; Hypertension; Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Costa Rica, Los Yoses, San Pedro San Jose, Los Yoses, San Pedro, Costa Rica, 11501
Egypt, Alexandria Fleming, Alexandria, Egypt, NA
Egypt, Assiut downtown, Assiut, Egypt, NA
Egypt, Cairo Haram, Cairo, Egypt, NA
India Delhi, India, 110063
India Pondicherry, India, 605014
India Vadodara, India, 390023
India, Gujarat Ahmedabad, Gujarat, India, 380015
India, Haryana Rohtak, Haryana, India, 124514
India, Karnataka Bangalore, Karnataka, India, 560010
India, Maharashtra Pune, Maharashtra, India, 411001
India, Royapuram Chennai, Royapuram, India, 600013
India, West Bengal Kolkata, West Bengal, India, 700098
Malaysia, Iskandar Puteri Johor Darul Takzim, Iskandar Puteri, Malaysia, 79250
Mexico, Chihuahua Chihuahua, Mexico, 31217
Mexico, Jalisco Guadalajara, Jalisco, Mexico, 44670
Mexico, Jalisco Guadalajara, Jalisco, Mexico, 44340
Mexico, Jalisco Guadalajara, Jalisco, Mexico, 44600
Mexico, Nuevo Leon Monterrey, Nuevo Leon, Mexico, 64460
Mexico, Queretaro San Juan del Rio, Queretaro, Mexico, 76800